https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-01-01 / Surgery 2002 Jan;131(1 Suppl):S121-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-01-01 / Surgery 2002 Jan;131(1 Suppl):S121-72002-01-01 00:00:002019-02-15 09:17:55Hyperthermia for rectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-01-01 / Med. Oncol. 2002;19(4):213-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-01-01 / Med. Oncol. 2002;19(4):213-82002-01-01 00:00:002019-02-15 08:51:08Dendritic cell vaccines in the treatment of multiple myeloma: advances and limitations
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-01-01 / Int J Gastrointest Cancer 2002;32(1):1-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-01-01 / Int J Gastrointest Cancer 2002;32(1):1-62002-01-01 00:00:002019-02-15 08:52:35The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-12-01 / Cancer Res. 2001 Dec;61(23):8361-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-12-01 / Cancer Res. 2001 Dec;61(23):8361-52001-12-01 00:00:002001-12-01 00:00:00Heat shock and heat shock protein 70i enhance the oncolytic effect of replicative adenovirus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-12-01 / Cancer Res. 2001 Dec;61(23):8513-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-12-01 / Cancer Res. 2001 Dec;61(23):8513-92001-12-01 00:00:002019-02-15 08:53:19Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-11-01 / Hepatology 2001 Nov;34(5):896-905
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-11-01 / Hepatology 2001 Nov;34(5):896-9052001-11-01 00:00:002019-02-15 09:13:28Effective treatment of small murine hepatocellular carcinoma by dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-11-01 / Exp. Hematol. 2001 Nov;29(11):1247-55
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-11-01 / Exp. Hematol. 2001 Nov;29(11):1247-552001-11-01 00:00:002001-11-01 00:00:00Dendritic cells in cancer vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-10-22 / Cancer Lett. 2001 Oct;172(1):27-36
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-10-22 / Cancer Lett. 2001 Oct;172(1):27-362001-10-22 00:00:002019-02-15 09:22:29Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-10-01 / J. Clin. Endocrinol. Metab. 2001 Oct;86(10):4965-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-10-01 / J. Clin. Endocrinol. Metab. 2001 Oct;86(10):4965-92001-10-01 00:00:002019-02-15 08:53:33Immunotherapy for medullary thyroid carcinoma by dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-09-01 / Cancer Immunol. Immunother. 2001 Sep;50(7):337-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-09-01 / Cancer Immunol. Immunother. 2001 Sep;50(7):337-442001-09-01 00:00:002019-02-15 08:47:02Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells
